The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would ...
6hon MSN
Members of the Sackler family who own the OxyContin maker Purdue Pharma would hand over the company and up to $7 billion in cash in the latest plan to settle thousands of lawsuits over the toll of ...
The plan put forth Tuesday could see the Sackler family pay up to $7 billion. Also in the news: Merck prepares to close its manufacturing plant in Pennsylvania; Optum Rx, which includes UnitedHealth ...
Purdue Pharma and the Sackler family who own the company have proposed a new $7.4 billion settlement to resolve ... criticism as it would grant the Sacklers immunity from future civil ...
Members of the Sackler Family, and Purdue Pharma ... The new settlement is not a done deal and could be upended by a requirement the Sacklers are allegedly pushing that $800M be set aside from ...
Purdue Pharma and the members of the Sackler ... although Purdue filed for bankruptcy protections, the Sacklers themselves did not. New York Attorney General Letitia James (D) said the overall ...
STORY: Purdue Pharma and its Sackler family owners rose to ... the company's previous attempt to resolve the lawsuits in a bankruptcy settlement. That deal would have granted the Sacklers ...
The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback